Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Pharmacodynamics of Doxorubicin in Children, Adolescents and Young Adults With Newly Diagnosed Osteosarcoma, Ewing Tumours and Hodgkin Lymphoma
2011-005554-62Phase 4Completed
- Sponsor
- Australia and New Zealand Sarcoma Association
- Start
- Mar 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doxorubicin in osteosarcoma (OS), Ewing sarcoma and Hodgkin lymphoma (HL), sponsored by Australia and New Zealand Sarcoma Association. Started Mar 2012; status: completed.
02
Drugs
doxorubicin
03
Conditions
osteosarcoma (OS)Ewing sarcomaHodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2011-005554-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005554-62.